Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy for recurrent miscarriage.

T F Porter1, Y LaCoursiere, J R Scott

  • 1LDS Hospital, Maternal-Fetal Medicine, 8th Avenue and C Street, Salt Lake City, Utah 84105, USA. flint.porter@intermountainmail.org

The Cochrane Database of Systematic Reviews
|April 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes.

IJTLD open·2024
Same author

Optogenetic stimulation of striatal patches modifies habit formation and inhibits dopamine release.

Scientific reports·2021
Same author

Characterization of host response, resorption, and strength properties, and performance in the presence of bacteria for fully absorbable biomaterials for soft tissue repair.

Hernia : the journal of hernias and abdominal wall surgery·2017
Same author

Fourier transform mass spectrometry-advancing years (1992-mid. 1996).

Mass spectrometry reviews·2016
Same author

Recurrent early pregnancy loss and antiphospholipid antibodies: where do we stand?

Lupus·2014
Same author

A risk stratification model to predict adverse neonatal outcome in labor.

Journal of perinatology : official journal of the California Perinatal Association·2013
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
Same journal

Non-pharmacological interventions for anxiety and depression in Parkinson's disease.

The Cochrane database of systematic reviews·2026
Same journal

Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis.

The Cochrane database of systematic reviews·2026
See all related articles

Immunotherapies like paternal leukocyte immunization and intravenous immune globulin do not significantly improve live birth rates in women with recurrent pregnancy loss. These treatments showed no significant benefit over placebo for improving subsequent live births.

Area of Science:

  • Reproductive Immunology
  • Obstetrics
  • Clinical Trials

Background:

  • Immunological factors are implicated in unexplained recurrent pregnancy loss (RPL).
  • Immunotherapies have been explored as treatments for RPL.
  • Paternal leukocyte immunization and intravenous immune globulin (IVIG) are among these therapies.

Purpose of the Study:

  • To review the efficacy of immunotherapies in improving live birth rates for women with unexplained RPL.
  • To assess treatments including paternal leukocyte immunization and IVIG.

Main Methods:

  • Systematic review of high-quality randomized controlled trials.
  • Searched major databases (Cochrane, MEDLINE, EMBASE) up to 2005.
  • Included women with ≥3 miscarriages, ≤1 live birth, and no identified non-immunologic causes.

Related Experiment Videos

Main Results:

  • Twenty trials were analyzed.
  • Paternal cell immunization (12 trials) showed no significant difference in live births (Peto OR 1.23, 95% CI 0.89-1.70).
  • Third party donor cells, trophoblast membranes, and IVIG also demonstrated no significant benefit over placebo.

Conclusions:

  • Current evidence suggests immunotherapies do not offer a significant advantage over placebo for RPL.
  • Paternal cell immunization, donor leukocytes, trophoblast membranes, and IVIG are not proven effective.
  • Further research may be needed to identify effective RPL treatments.